Blog
RSS FeedPosted by Michael Wonder on 07 May 2020
NICE draft guidance recommends new treatment option for people with early breast cancer
7 May 2020 - NICE has today published draft guidance which recommends trastuzumab emtansine (also called Kadcyla and made by Roche) ...
Posted by Michael Wonder on 30 Apr 2020
NICE joins international collaboratives to respond to the COVID-19 pandemic
30 April 2020 - NICE is supporting a growing number of international collaborations to share knowledge and identify treatments in response ...
Posted by Michael Wonder on 28 Apr 2020
NICE U-turn backs Stelara for ulcerative colitis
28 April 2020 - NICE has now issued a positive Final Appraisal Document recommending Janssen's Stelara (ustekinumab) as an option ...
Posted by Michael Wonder on 23 Apr 2020
NICE publishes two new COVID-19 guidelines
23 April 2020 - NICE has published 2 new rapid COVID-19 guidelines on the care of patients with suspected and confirmed ...
Posted by Michael Wonder on 22 Apr 2020
UK underinvested in health care, says pharma boss
22 April 2020 - The UK has underinvested in health care "over many years" which has hampered its ability to ...
Posted by Michael Wonder on 21 Apr 2020
Andexanet alfa for reversing anticoagulation
21 April 2020 - The Department of Health and Social Care has asked NICE to produce guidance on using andexanet alfa ...
Posted by Michael Wonder on 21 Apr 2020
NICE recommends Vitrakvi (larotrectinib) for use on Cancer Drugs Fund
21 April 2020 - Larotrectinib has been given a positive opinion by NICE, following the submission of a revised price after ...
Posted by Michael Wonder on 16 Apr 2020
Aid groups ask UK gov to stop pharma 'profiteering' from COVID-19
16 April 2020 - As of this morning – Thursday April 16 – the current recorded case count for COVID-19 ...
Posted by Michael Wonder on 09 Apr 2020
NICE publishes new COVID-19 guidelines on cystic fibrosis, chronic obstructive pulmonary disease and dermatological conditions treated with drugs affecting the immune response
9 April 2020 - NICE has today published 3 new rapid guidelines on the care of patients with suspected and confirmed ...
Posted by Michael Wonder on 04 Apr 2020
NICE publishes new COVID-19 guidelines on severe asthma, pneumonia, rheumatological disorders and symptom management
4 April 2020 - They cover the management of patients with severe asthma, pneumonia, rheumatological autoimmune, inflammatory and metabolic bone disorders ...
Posted by Michael Wonder on 02 Apr 2020
A NICE transformation?
1 April 2020 - Will the NICE Review of Methods and Processes pave the way to HTA reform? ...
Posted by Michael Wonder on 21 Mar 2020
NICE publishes first rapid COVID-19 guidelines
21 March 2020 - New guidelines cover the management of patients in critical care, the management of patients who are having ...
Posted by Michael Wonder on 18 Mar 2020
Professor Gillian Leng, CBE, appointed as new NICE Chief Executive
18 March 2020 - Gillian has held the post of Deputy Chief Executive at NICE since 2007 and is also currently ...
Posted by Michael Wonder on 17 Mar 2020
NICE publishes its first medtech briefing on artificial intelligence software
17 March 2020 - NICE publishes a Medtech Innovation Briefing on artificial intelligence for analysing CT brain scans. ...
Posted by Michael Wonder on 16 Mar 2020
A systematic review of economic evaluations of advanced therapy medicinal products
10 March 2020 - Advanced therapy medicinal products represent a new category of medicinal products with a potential for transformative improvements ...